Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4Phase 1 4Phase 1/2 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 7Breast Neoplasms 7Colorectal Neoplasms 6Stomach Neoplasms 5Neoplasms 5Sarcoma 3Precision Cell Immunotherapy 3Ovarian Neoplasms 3Neoplasm Metastasis 3Mesothelioma, Malignant 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hodgkin Disease 3Glioblastoma 3Esophageal Neoplasms 3Wilms Tumor 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Mesothelioma 2Melanoma 2Lymphoma 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Ovarian Epithelial 2Virus Diseases 1

Interventions

Carboplatin 16Paclitaxel 9Cyclophosphamide 8liposomal doxorubicin 6Peripheral Blood Stem Cell Transplantation 6Topotecan 5Filgrastim 5pembrolizumab 4Docetaxel 4oregovomab 3veliparib 2sacituzumab govitecan 2epacadostat 2avelumab 2Thiotepa 2Taxes 2STA 9090 2Nivolumab 2Erlotinib Hydrochloride 2Drug Therapy 2Cisplatin 2Amifostine 2talazoparib 1ribociclib 1relacorilant 1ralimetinib 1poly ICLC 1phenoxodiol 1peginterferon alfa-2b 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Ovarian Epithelial × Drug Therapy × Clear all
NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04620954 2021-12-01

ORION-02

National Cancer Centre, Singapore

Phase 1/2 Unknown
31 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡